152 related articles for article (PubMed ID: 29638121)
1. An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
Garrison AT; Abouelhassan Y; Kallifidas D; Tan H; Kim YS; Jin S; Luesch H; Huigens RW
J Med Chem; 2018 May; 61(9):3962-3983. PubMed ID: 29638121
[TBL] [Abstract][Full Text] [Related]
2. A Highly Potent Class of Halogenated Phenazine Antibacterial and Biofilm-Eradicating Agents Accessed Through a Modular Wohl-Aue Synthesis.
Yang H; Abouelhassan Y; Burch GM; Kallifidas D; Huang G; Yousaf H; Jin S; Luesch H; Huigens RW
Sci Rep; 2017 May; 7(1):2003. PubMed ID: 28515440
[TBL] [Abstract][Full Text] [Related]
3. Halogenated Phenazines that Potently Eradicate Biofilms, MRSA Persister Cells in Non-Biofilm Cultures, and Mycobacterium tuberculosis.
Garrison AT; Abouelhassan Y; Kallifidas D; Bai F; Ukhanova M; Mai V; Jin S; Luesch H; Huigens RW
Angew Chem Int Ed Engl; 2015 Dec; 54(49):14819-23. PubMed ID: 26480852
[TBL] [Abstract][Full Text] [Related]
4. Modular Synthetic Routes to Fluorine-Containing Halogenated Phenazine and Acridine Agents That Induce Rapid Iron Starvation in Methicillin-Resistant
Liu K; Brivio M; Xiao T; Norwood VM; Kim YS; Jin S; Papagni A; Vaghi L; Huigens RW
ACS Infect Dis; 2022 Feb; 8(2):280-295. PubMed ID: 35089005
[TBL] [Abstract][Full Text] [Related]
5. Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Garrison AT; Abouelhassan Y; Norwood VM; Kallifidas D; Bai F; Nguyen MT; Rolfe M; Burch GM; Jin S; Luesch H; Huigens RW
J Med Chem; 2016 Apr; 59(8):3808-25. PubMed ID: 27018907
[TBL] [Abstract][Full Text] [Related]
6. Halogenated quinolines discovered through reductive amination with potent eradication activities against MRSA, MRSE and VRE biofilms.
Basak A; Abouelhassan Y; Huigens RW
Org Biomol Chem; 2015 Nov; 13(41):10290-4. PubMed ID: 26414088
[TBL] [Abstract][Full Text] [Related]
7. A Modular Synthetic Route Involving
Yang H; Kundra S; Chojnacki M; Liu K; Fuse MA; Abouelhassan Y; Kallifidas D; Zhang P; Huang G; Jin S; Ding Y; Luesch H; Rohde KH; Dunman PM; Lemos JA; Huigens RW
J Med Chem; 2021 Jun; 64(11):7275-7295. PubMed ID: 33881312
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of Carbonate-Linked Halogenated Phenazine-Quinone Prodrugs with Improved Water-Solubility and Potent Antibacterial Profiles.
Xiao T; Liu K; Gao Q; Chen M; Kim YS; Jin S; Ding Y; Huigens RW
ACS Infect Dis; 2023 Apr; 9(4):899-915. PubMed ID: 36867688
[TBL] [Abstract][Full Text] [Related]
9. Starving Bacteria of Iron: A Potential Strategy to Disperse Bacterial Biofilms.
Naclerio GA; Sintim HO
J Med Chem; 2021 Jun; 64(11):7272-7274. PubMed ID: 33988992
[TBL] [Abstract][Full Text] [Related]
10. Synthetically Tuning the 2-Position of Halogenated Quinolines: Optimizing Antibacterial and Biofilm Eradication Activities via Alkylation and Reductive Amination Pathways.
Basak A; Abouelhassan Y; Norwood VM; Bai F; Nguyen MT; Jin S; Huigens RW
Chemistry; 2016 Jun; 22(27):9181-9. PubMed ID: 27245927
[TBL] [Abstract][Full Text] [Related]
11. Transcript Profiling of MRSA Biofilms Treated with a Halogenated Phenazine Eradicating Agent: A Platform for Defining Cellular Targets and Pathways Critical to Biofilm Survival.
Abouelhassan Y; Zhang Y; Jin S; Huigens RW
Angew Chem Int Ed Engl; 2018 Nov; 57(47):15523-15528. PubMed ID: 30230671
[TBL] [Abstract][Full Text] [Related]
12. Identification of N-Arylated NH125 Analogues as Rapid Eradicating Agents against MRSA Persister Cells and Potent Biofilm Killers of Gram-Positive Pathogens.
Abouelhassan Y; Basak A; Yousaf H; Huigens RW
Chembiochem; 2017 Feb; 18(4):352-357. PubMed ID: 27925693
[TBL] [Abstract][Full Text] [Related]
13. Phenazine Antibiotic-Inspired Discovery of Bacterial Biofilm-Eradicating Agents.
Huigens RW; Abouelhassan Y; Yang H
Chembiochem; 2019 Dec; 20(23):2885-2902. PubMed ID: 30811834
[TBL] [Abstract][Full Text] [Related]
14. Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.
Xiao T; Liu K; Huigens RW
Bioorg Med Chem Lett; 2020 Nov; 30(22):127515. PubMed ID: 32860978
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of a halogenated phenazine-erythromycin conjugate prodrug for antibacterial applications.
Yang H; Liu K; Jin S; Huigens Iii RW
Org Biomol Chem; 2021 Feb; 19(7):1483-1487. PubMed ID: 33521803
[TBL] [Abstract][Full Text] [Related]
16. Simple synthesis of endophenazine G and other phenazines and their evaluation as anti-methicillin-resistant Staphylococcus aureus agents.
Udumula V; Endres JL; Harper CN; Jaramillo L; Zhong HA; Bayles KW; Conda-Sheridan M
Eur J Med Chem; 2017 Jan; 125():710-721. PubMed ID: 27721155
[TBL] [Abstract][Full Text] [Related]
17. Halogenated quinolines bearing polar functionality at the 2-position: Identification of new antibacterial agents with enhanced activity against Staphylococcus epidermidis.
Basak A; Abouelhassan Y; Kim YS; Norwood VM; Jin S; Huigens RW
Eur J Med Chem; 2018 Jul; 155():705-713. PubMed ID: 29936357
[TBL] [Abstract][Full Text] [Related]
18. Targeting bacterial biofilms with persister-killing agents.
Huigens RW
Future Med Chem; 2021 Feb; 13(3):225-228. PubMed ID: 33225755
[No Abstract] [Full Text] [Related]
19. Synthesis, biological evaluation, and metabolic stability of phenazine derivatives as antibacterial agents.
Krishnaiah M; de Almeida NR; Udumula V; Song Z; Chhonker YS; Abdelmoaty MM; do Nascimento VA; Murry DJ; Conda-Sheridan M
Eur J Med Chem; 2018 Jan; 143():936-947. PubMed ID: 29227933
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
